Peberdy MA - Search Results

1

Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).

Abbate A, Van Tassell BW, Christopher S, Abouzaki NA, Sonnino C, Oddi C, Carbone S, Melchior RD, Gambill ML, Roberts CS, Kontos MC, Peberdy MA, Toldo S, Vetrovec GW, Biondi-Zoccai G, Dinarello CA. Abbate A, et al. Among authors: peberdy ma. Am J Cardiol. 2015 Jan 1;115(1):8-12. doi: 10.1016/j.amjcard.2014.09.043. Epub 2014 Oct 13. Am J Cardiol. 2015. PMID: 25456867 Clinical Trial.

2

Usefulness of decrease in oxygen uptake efficiency slope to identify myocardial perfusion defects in men undergoing myocardial ischemic evaluation.

Pinkstaff S, Peberdy MA, Kontos MC, Fabiato A, Finucane S, Arena R. Pinkstaff S, et al. Among authors: peberdy ma. Am J Cardiol. 2010 Dec 1;106(11):1534-9. doi: 10.1016/j.amjcard.2010.07.034. Epub 2010 Oct 14. Am J Cardiol. 2010. PMID: 21094351

3

Differences in equations used to estimate aerobic capacity in patients being assessed for suspected myocardial ischemia.

Arena R, Pinkstaff S, Peberdy MA, Kontos MC, Finucane S, Forman DE. Arena R, et al. Among authors: peberdy ma. Am J Cardiol. 2011 Oct 15;108(8):1198-9. doi: 10.1016/j.amjcard.2011.07.034. Am J Cardiol. 2011. PMID: 21985952 No abstract available.

4

Overestimation of aerobic capacity with the bruce treadmill protocol in patients being assessed for suspected myocardial ischemia.

Pinkstaff S, Peberdy MA, Kontos MC, Fabiato A, Finucane S, Arena R. Pinkstaff S, et al. Among authors: peberdy ma. J Cardiopulm Rehabil Prev. 2011 Jul-Aug;31(4):254-60. doi: 10.1097/HCR.0b013e318211e3ed. J Cardiopulm Rehabil Prev. 2011. PMID: 21427601

5

Quantifying exertion level during exercise stress testing using percentage of age-predicted maximal heart rate, rate pressure product, and perceived exertion.

Pinkstaff S, Peberdy MA, Kontos MC, Finucane S, Arena R. Pinkstaff S, et al. Among authors: peberdy ma. Mayo Clin Proc. 2010 Dec;85(12):1095-100. doi: 10.4065/mcp.2010.0357. Mayo Clin Proc. 2010. PMID: 21123636 Free PMC article.

6

The influence of referral source on characteristics of patients undergoing cardiac stress testing: emergency department versus outpatient office.

Pinkstaff S, Peberdy MA, Kontos MC, Finucane S, Lavie CJ, Arena R. Pinkstaff S, et al. Among authors: peberdy ma. Postgrad Med. 2011 Mar;123(2):36-41. doi: 10.3810/pgm.2011.03.2261. Postgrad Med. 2011. PMID: 21474891

7

Influence of etiology of heart failure on the obesity paradox.

Arena R, Myers J, Abella J, Pinkstaff S, Brubaker P, Moore B, Kitzman D, Peberdy MA, Bensimhon D, Chase P, Forman D, West E, Guazzi M. Arena R, et al. Among authors: peberdy ma. Am J Cardiol. 2009 Oct 15;104(8):1116-21. doi: 10.1016/j.amjcard.2009.05.059. Epub 2009 Aug 28. Am J Cardiol. 2009. PMID: 19801034 Free PMC article.

8

Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.

Zheng G, Xu J, He F, Hu J, Ge W, Ji X, Wang C, Bradley JL, Peberdy MA, Ornato JP, Toldo S, Wang T, Tang W. Zheng G, et al. Among authors: peberdy ma. Biomed Pharmacother. 2021 Nov;143:112093. doi: 10.1016/j.biopha.2021.112093. Epub 2021 Aug 30. Biomed Pharmacother. 2021. PMID: 34474352 Free article.

9

The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: influence of beta-blockade.

Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, Guazzi M. Arena R, et al. Among authors: peberdy ma. Int J Cardiol. 2010 Jan 21;138(2):166-73. doi: 10.1016/j.ijcard.2008.08.010. Epub 2008 Sep 20. Int J Cardiol. 2010. PMID: 18804882 Clinical Trial.

10

The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation.

Zheng G, He F, Xu J, Hu J, Ge W, Ji X, Wang C, Bradley JL, Peberdy MA, Ornato JP, Jiang L, Toldo S, Wang T, Tang W. Zheng G, et al. Among authors: peberdy ma. Cardiovasc Drugs Ther. 2023 Jun;37(3):423-433. doi: 10.1007/s10557-021-07282-z. Epub 2022 Jan 1. Cardiovasc Drugs Ther. 2023. PMID: 34973094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page